Vaccination Against High Risk Breast Cancer Using Tumor Derived Heat Shock Protein 70
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: BIOLOGICAL: Heat Shock Protein 70-peptide complexes (HSP70)
Sponsor: UConn Health